<DOC>
	<DOCNO>NCT01652209</DOCNO>
	<brief_summary>Through injection Hearticellgram-AMI acute myocardial infarction patient primary target drug , long term efficacy improvement leave ventricle ejection fraction upon first cell treatment evaluate compare current exist treatment ( contemporary drug treatment ) .This study also compare efficacy safety single dose hearticellgram-AMI two dose regimen hearticellgram-AMI .</brief_summary>
	<brief_title>RELIEF ( A Randomized , Open labEled , muLticenter Trial Safety Efficacy Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarction )</brief_title>
	<detailed_description>We enrol patient successful conventional percutaneous coronary intervention acute myocardial infarction . Patients allocate one three group ( group1=comparator , group2= one dose hearticellgram-AMI , group 3= two dose hearticellgram-AMI ) . single dose hearticellgram-AMI attain new drug approval MFDS ( related NCT01392105 ) .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>1 . Between age 2070 2 . Left Ventricular Ejection Fraction ( LVEF ) 45 % 3 . Acute myocardial infarction patient fulfil least one give quality , use electrocardiogram ( 12lead ECG ) A. STsegment elevation 0.1 mV two limb lead B . 0.2 mV elevation two contiguous precordial lead , indicative AMI 4 . Anterior Wall MI 5 . Patients fulfill criterion also experience successful reperfusion 6 . Patients consent participate clinical trial personally , well legal attorney 1 . Patients diagnose malignant bloodrelated disease ( acute myelocyte leukemia , acute lymphatic leukemia , nonHodgkin 's lymphoma , multiple myeloma ) , improve 2 . Patients severe aplastic anemia 3 . Patients solid cancer previous medical history ( within 5 year ) 4 . Patients whose blood serum AST/ASL rate three time normal maximum rate , whose creatinine rate 1.5 time normal maximum rate ( AST myocardial infarction patient temporarily rise , thus , decide researcher , damage liver function , rise take consideration ) 5 . Patients implement Coronary Artery Bypass Graft ( CABG ) 6 . Patients chronic heart failure ( patient medical history heart failure medical history least three month occurrence acute myocardial infarction ) 7 . Patients proceed cardiac catheterization 8 . Patients continuously take large dos steroid ( 1mg/kg/day ) antibiotic severe infection one month prior registration 9 . Patients major surgical operation , organ biopsy , significant external injury determine researcher , within three month registration 10 . Patients head injury external injury development myocardial infarction 11. patient stroke transient ischemic attack within six month registration , patient history central nervous system disease ( tumor , aneurysm , brain surgery etc . ) 12 . Patients low survival ability cardiopulmonary resuscitation within last 2 week . 13 . Patients positive HIV , HBV , HCV , Syphilis 14. pregnant woman likely pregnant lactate woman 15. patient compliance protocol . 16. patient drug abuser within last 1 year . 17. patient participate clinical trial last 1 month . 18. patient likely tumor tumor marker test patient diagnose cancer national cancer screen project . 19. inappropriate patient participate study investigator 's opinion .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>